Navigation Links
Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast
Date:2/14/2008

EMERYVILLE, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will webcast a teleconference with management to discuss fourth quarter and full year 2007 financial results and provide a business overview on Tuesday, February 19, 2008, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for the fourth quarter and year ended December 31, 2007 will be released earlier that day.

Interested parties may access a live webcast of the presentation at: http://webcast.streamlogics.com/audience/index.asp?eventid=62782 or by dialing 847-413-3238 and using the passcode 20350141. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 20350141 approximately one hour after the teleconference concludes. The replay will be available through March 19, 2008.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. Nexavar is currently approved for the treatment of advanced kidney cancer and for the treatment of liver cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer and other tumor types. For more information about Onyx, visit the company's website at: http://www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered t
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vion Pharmaceuticals Holds Special Meeting of Stockholders
3. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
4. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
5. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
6. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
9. Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
10. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
11. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Portage Biotech Inc. ("Portage" or "the Company" )) (OTC ... announce that the Company will be presenting  at the ... held in London, UK . Portage,s ... James Mellon , a director of Portage, will provide ... at its subsidiaries, Portage Pharmaceuticals Ltd. ("PPL"), and Biohaven ...
(Date:4/16/2015)... 2015 ChemRar High ... and R&D group, and Lancet, Russian Distribution ... and commercialization of new medicines in ... to stimulate the innovative development of the ... http://photos.prnewswire.com/prnh/20150416/739742-a) ,     (Logo: http://photos.prnewswire.com/prnh/20150416/739742-b) , ...
(Date:4/16/2015)... , April 16, 2015  Scientists from Cleave ... Drugs on the Horizon," at the American Association for ... PA on Sunday, April 19, 2015 from ... Cleave,s Director of Biology, will present new in vivo ... first-in-class, oral inhibitor of p97, a critical enzyme that ...
(Date:4/16/2015)... , Switzerland , ... Debiopharm International SA (Debiopharm), part of Debiopharm Group ™ , ... drugs that target unmet medical needs as ... preclinical data on the investigational compounds Debio 1143 ... will be presented at the 2015 Annual ...
Breaking Biology Technology:Portage to Present at Master Investor 2015 in London, UK 2Portage to Present at Master Investor 2015 in London, UK 3Portage to Present at Master Investor 2015 in London, UK 4Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
... July 25, 2011 MiMedx Group, Inc.  (OTCBB: MDXG), ... regenerative biomaterials and bioimplants processed from human amniotic membrane, ... six months ended June 30, 2011. The ... an 85% percent increase over first quarter of 2011 ...
... ERT (NASDAQ: ERT ) announced today that it ... Monday, August 1, after the market closes.  After the release, ... ET that day. For the conference call, ... States or 1-412-858-4600 when calling internationally. There will be a ...
... SHELTON, Conn., July 22, 2011 Modern Plastics, one ... stock shapes and medical-grade plastics, has moved from ... new address is 88 Long Hill Cross Road, Shelton, ... features an advanced environmentally controlled clean room for storage ...
Cached Biology Technology:MiMedx Group Announces Second Quarter 2011 Results 2MiMedx Group Announces Second Quarter 2011 Results 3MiMedx Group Announces Second Quarter 2011 Results 4MiMedx Group Announces Second Quarter 2011 Results 5MiMedx Group Announces Second Quarter 2011 Results 6MiMedx Group Announces Second Quarter 2011 Results 7MiMedx Group Announces Second Quarter 2011 Results 8MiMedx Group Announces Second Quarter 2011 Results 9MiMedx Group Announces Second Quarter 2011 Results 10ERT Reports Second Quarter 2011 Operating Results on August 1, 2011 2
(Date:4/6/2015)... , Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/143028 for MINIATURE, MULTI-PURPOSE ... TRANSFER  NXT-ID introduces a new revolutionary ... patent surrounds the use of miniature antenna modules ...
(Date:4/1/2015)... 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces the second ... is underway to early access pre-order customers. ... at retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, ... was accepted at all outlets and very easy to ...
(Date:3/26/2015)... 26, 2015 The Granite Club, ... and athletic club, today announced it has implemented a ... of movement for members and staff, while restricting access ... process, we selected FST,s IMID Access system because it ... our members and staff, in addition to unparalleled security," ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... bioMETRX Inc., (OTC,Bulletin Board: BMRX), today announced ... agreement with EZ Print, LLC for the advanced ... purchase,agreement., EZ Print, LLC will invest considerable ... the enterprise document production,business. Currently the technology branded ...
... largest field trial of its kind in the United ... Miscanthus x giganteus outperforms current biofuels sources by ... production in the U.S. could significantly reduce the acreage ... the researchers report. The new findings, from researchers ...
... (CLIC), a group of researchers from 10 academic and ... by physicians at Case Western Reserve University School of ... grant from the National Institutes of Health (NIH) to ... deficiency that causes AIDS. The grant will fund four ...
Cached Biology News:bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC 2bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC 3Miscanthus can meet US biofuels goal using less land than corn or switchgrass 2Miscanthus can meet US biofuels goal using less land than corn or switchgrass 3Case Western Reserve University School of Medicine researchers receive $10.8 million 2
For removal of the zona pellucida. Sterile, Mouse Embryo tested...
Request Info...
Imject Freund's Complete Adjuvant (FCA)...
... the secretion of cytoplasmic granules, is ... response of leukocytes (e.g. basophils, neutrophils, ... to histamine, these secretory granules contain ... chemokines, and many proteases (Hallgren, 2001). ...
Biology Products: